CIBC Asset Management Inc grew its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 90,662 shares of the financial services provider’s stock after buying an additional 559 shares during the period. CIBC Asset Management Inc’s holdings in Aflac were worth $9,378,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new position in shares of Aflac in the third quarter worth approximately $34,000. Raelipskie Partnership bought a new position in shares of Aflac in the third quarter worth approximately $38,000. Covestor Ltd increased its position in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares during the last quarter. Kennebec Savings Bank bought a new position in shares of Aflac in the third quarter worth approximately $45,000. Finally, Catalyst Capital Advisors LLC bought a new position in shares of Aflac in the third quarter worth approximately $51,000. 67.44% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.90% of the company’s stock.
Aflac Stock Performance
Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities research analysts predict that Aflac Incorporated will post 6.95 earnings per share for the current year.
Aflac Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be given a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 annualized dividend and a yield of 2.23%. This is a positive change from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio (DPR) is currently 20.83%.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the stock. Keefe, Bruyette & Woods decreased their price objective on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Piper Sandler decreased their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Barclays reduced their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, February 7th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Finally, Evercore ISI reduced their price target on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research report on Wednesday, December 4th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $103.00.
Read Our Latest Stock Report on AFL
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Russell 2000 Index, How Investors Use it For Profitable Trading
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.